Ireland· IE-PA-EU/1/11/696/001-004
Bydureon 2 mg powder and solvent for prolonged-release suspension for injection
A exenatid product containing exenatide, registered in Ireland by AstraZeneca AB.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Exenatide
- Manufacturer
- AstraZeneca AB
- Country
- Ireland (IE)
- ATC code
- A10BX04
- ATC class
- Exenatid
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/11/696/001-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
407 interactions on record for exenatid.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Exenatid · interactions on record
407 records
- 3 severe
- 359 moderate
- 42 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- MannitolA06AD16moderate
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Exenatid in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceBYDUREON 2 mg, poudre et solvant pour suspension injectable à libération prolongée en stylo prérempliASTRAZENECA AB
- United KingdomBydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pensCST Pharma Ltd
- United StatesByettaAstraZeneca Pharmaceuticals LP
- FinlandBydureonAstraZeneca AB
- BelgiumBydureon 2 mgAstraZeneca
- SpainBYDUREON 2 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAstrazeneca Ab
- ItalyBYDUREON*4 penne preriempite Bcise SC 2 mg 0,85 ml rilascio prolungatoASTRAZENECA AB
- NorwayBydureonAstraZeneca
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/410ab357-c454-4f16-8b2f-06974af575b8 GET /v1/drugs/410ab357-c454-4f16-8b2f-06974af575b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for prolonged-release suspension for injection in pre-filled pen",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"A10BX",
"A10BX04"
],
"strength": null,
"pa_number": "EU/1/11/696/001-004",
"substances": [
"Exenatide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about exenatid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.